This list is an analysis based on recent market events. It's not an investment recommendation.
About
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand. The company's cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Vitrafy Life Sciences stocks are traded under the ticker VFYLF.
When is the next Vitrafy Life Sciences earnings date?▼
Vitrafy Life Sciences is going to release the next earnings report on February 11, 2027.
What is Vitrafy Life Sciences revenue for the last year?▼
Vitrafy Life Sciences revenue for the last year amounts to 116,649.84 USD.
What is Vitrafy Life Sciences net income for the last year?▼
VFYLF net income for the last year is -11.01M USD.
In which sector is Vitrafy Life Sciences located?▼
Vitrafy Life Sciences operates in the Other sector.
When did Vitrafy Life Sciences complete a stock split?▼
Vitrafy Life Sciences has not had any recent stock splits.